These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1890541)

  • 1. Selection criteria for liver transplant donors.
    Schroeder TJ; Pesce AJ; Ryckman FC; Tressler TP; Brunson ME; Pedersen SH; Tchervenkov JI; Penn I; Alexander JW; Balistreri WF
    J Clin Lab Anal; 1991; 5(4):275-7. PubMed ID: 1890541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoethylglycinexylide formation in assessing pediatric donor liver function.
    Rossi SJ; Schroeder TJ; Vine WH; A-Kader HH; Gremse DA; Ryckman FC; Pedersen SH; Pesce AJ; Balistreri WF
    Ther Drug Monit; 1992 Dec; 14(6):452-6. PubMed ID: 1485364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective multivariate analysis of donor monoethylglycine xylidide (MEGX) testing in liver transplantation. Transplantation Society of Michigan Scientific Studies Committee.
    Woodside KJ; Merion RM; Williams TC
    Clin Transplant; 1998 Feb; 12(1):43-8. PubMed ID: 9541422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unreliability of the lidocaine/monoethylglycinexylidide test for assessment of liver donors.
    Reding R; Wallemacq P; de Ville de Goyet J; Lerut J; Hausleithner V; Feyaerts A; Lambotte L; Otte JB
    Transplantation; 1993 Aug; 56(2):323-6. PubMed ID: 8356585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.
    Fairchild R; Solomon H; Contis J; Kaminski D
    Arch Surg; 1996 Oct; 131(10):1099-102. PubMed ID: 8857911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
    Kupcová V; Turecký L; Szántová M; Schmidtová K
    Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lignocaine metabolite formation as a measure of pre-transplant liver function.
    Oellerich M; Burdelski M; Ringe B; Lamesch P; Gubernatis G; Bunzendahl H; Pichlmayr R; Herrmann H
    Lancet; 1989 Mar; 1(8639):640-2. PubMed ID: 2564460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery.
    Ercolani G; Grazi GL; Callivà R; Pierangeli F; Cescon M; Cavallari A; Mazziotti A
    Surgery; 2000 Apr; 127(4):464-71. PubMed ID: 10776439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of lidocaine as a test of liver function in liver transplantation.
    Potter JM; Oellerich M
    Liver Transpl Surg; 1996 May; 2(3):211-24. PubMed ID: 9346651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MEGX test: a tool for the real-time assessment of hepatic function.
    Oellerich M; Armstrong VW
    Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
    Burdelski M; Schütz E; Nolte-Buchholtz S; Armstrong VW; Oellerich M
    Ther Drug Monit; 1996 Aug; 18(4):378-82. PubMed ID: 8857554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient.
    Potter JM; Hickman PE; Henderson A; Balderson GA; Lynch SV; Strong RW
    Ther Drug Monit; 1996 Aug; 18(4):383-7. PubMed ID: 8857555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of lidocaine metabolite (monoethylglycinexylidide) as a liver function test].
    Shimanuki K; Suzuki W; Sakurabayashi I; Kiyozaki H; Shinohara K; Soda K; Kai T; Satake M; Miyata M
    Nihon Shokakibyo Gakkai Zasshi; 1993 Jan; 90(1):33-40. PubMed ID: 8433534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gender on the monoethylglycinexylidide test in normal subjects and liver donors.
    Oellerich M; Schütz E; Polzien F; Ringe B; Armstrong VW; Hartmann H; Burdelski M
    Ther Drug Monit; 1994 Jun; 16(3):225-31. PubMed ID: 8085276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of monoethylglycinexylidide as a liver function test in the liver transplant recipient.
    Potter JM; Hickman PE; Lynch SV; Henderson A; Wright M; Balderson G; Strong RW
    Transplantation; 1993 Dec; 56(6):1385-8. PubMed ID: 8279008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lignocaine metabolism and MEGX production in the liver transplant donor.
    Potter JM; Hickman PE; Balderson G; Lynch SV; Strong R
    Transplant Proc; 1992 Feb; 24(1):198-9. PubMed ID: 1539243
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical importance of conventional and quantitative liver function tests in liver transplantation.
    Tanaka E; Inomata S; Yasuhara H
    J Clin Pharm Ther; 2000 Dec; 25(6):411-9. PubMed ID: 11123494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of the donor MEGX test in predicting liver allograft recipient outcome.
    Potter JM; Balderson GA; Hickman PE; Henderson A; Wright M; Burrow B; Lynch SV; Ong TH; Strong RW
    Transplantation; 1994 Aug; 58(4):524-6. PubMed ID: 8073525
    [No Abstract]   [Full Text] [Related]  

  • 20. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.
    Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L
    Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.